The modern multidisciplinary tumour board, Pisa/IT, June 29-30, 2026

Preliminary programme | Local host | Preliminary faculty | Venue | Registration | Accommodation

Multidisciplinary tumour boards (MDTBs) are essential for collaborative decision-making, bringing specialists together to determine the best treatment strategies. As interventional radiologists (IRs) take on an increasingly active role in these discussions, their ability to present scientific evidence on local-regional therapies and advocate for their inclusion in treatment options is becoming more critical. While IRs excel in technical expertise, many have limited formal training in communication and leadership within the MDTB setting.

This specialized course, hosted by ESIR and IASIOS, offers a unique combination of scientific updates and hands-on communication training, equipping IRs with both the latest evidence on local-regional therapies and the skills to engage confidently in MDTB discussions. The programme is structured over two focused days.

On the first day, participants will engage in interactive exercises on conflict resolution, stakeholder analysis, and team dynamics, designed to reinforce essential soft skills through real-world scenarios. The day will conclude with a debrief session, ensuring that participants leave with concrete strategies to enhance their engagement and leadership within MDTBs.

On the following day, the focus will shift to the latest clinical evidence on primary liver, kidney, and colorectal liver cancers. Case-based discussions with multidisciplinary experts will provide valuable insights into how IR treatments are evaluated within MDTBs.

This course provides a unique opportunity to refine both clinical and communication expertise, enabling IRs to take a more active role in MDTB discussions and contribute to better patient outcomes.

Who should attend?

The course is open to interventional radiologists and their multidisciplinary colleagues from IASIOS centres, and they are eligible for free registration and travel allowance of up to €500 per person.

Participation of an IR in MDTBs is a key component of the CIRSE Standards of Quality Assurance in Interventional Oncology and a core requirement for IASIOS accreditation. For further details about your registration, please contact us at [email protected].

Preliminary programme

Local hosts

ESIR and IASIOS are thrilled to welcome Sarah Perugia, a leadership transformation specialist, to this course to lead the communication workshops. In her career, Sara has helped medical professionals refine their leadership presence, navigate high-stakes conversations with confidence, and foster collaborative teams. Through interactive coaching and hands-on workshops, she has empowered doctors to communicate with clarity, authority, and empathy – transforming not just teams, but also patient outcomes.

Preliminary faculty

TBA